Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine

Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine

Janet H Ford,1 Shonda A Foster,1 Virginia L Stauffer,1 Dustin D Ruff,1 Sheena K Aurora,1 Jan Versijpt2 1Eli Lilly and Company, Indianapolis, IN 46225, USA; 2Department of Neurology – Headache and Facial Pain Clinic, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Bru...

Full description

Bibliographic Details
Main Authors: Ford JH, Foster SA, Stauffer VL, Ruff DD, Aurora SK, Versijpt J
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Patient Preference and Adherence
Subjects:
Migraine
galcanezumab
Phase 3
HCRU: satisfaction
acute medication
Online Access:https://www.dovepress.com/patient-satisfaction-health-care-resource-utilization-and-acute-headac-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/patient-satisfaction-health-care-resource-utilization-and-acute-headac-peer-reviewed-article-PPA

Similar Items